Bruno Jeronimo Ponte

Bruno Jeronimo Ponte

Auto-generated profile, based on publicly available information

Bruno Jeronimo Ponte

Hospital Israelita Albert Einstein

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2024 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
BPBruno Jeronimo Ponte
Bruno Jeronimo Ponte
VDViviane Galli Dib
Viviane Galli Dib
ALAndressa Cristina Sposato Louzada
Andressa Cristina Sposato Louzada
JFJúlia Freire Castanheiras de Paiva Ferreira
Júlia Freire Castanheiras de Paiva Ferreira
LPLucas Lembrança Pinheiro
Lucas Lembrança Pinheiro
NWNelson Wolosker
Nelson Wolosker
Spontaneous non-aneurysmal aortic rupture is rare and is usually attributed to penetrating aortic ulcers, infections, tumor infiltrations, or inflammatory and collagen diseases. Chronic rupture is infrequent but extremely rare in non-aneurysmal aortas, which makes diagnosis difficult because the absence of an aneurysm can mislead the physician to rule out rupture. Here, we describe the case of an 85-year-old male, who was undergoing oncological investigation for weight loss, inappetence, and back pain. Computed tomography and magnetic resonance imaging performed 3

23 July 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
BPBruno Jeronimo Ponte
Bruno Jeronimo Ponte
CSCarolina Carvalho Jansen Sorbello
Carolina Carvalho Jansen Sorbello
RORicardo Ferreira Mendes de Oliveira
Ricardo Ferreira Mendes de Oliveira
MPMaria Fernanda Cassino Portugal
Maria Fernanda Cassino Portugal
ALAndressa Cristina Sposato Louzada
Andressa Cristina Sposato Louzada
NWNelson Wolosker
Nelson Wolosker
Highlights ■ Assessing how vascular access devices affect quality of life is essential to effectively manage chemotherapy patients. ■ The translation and validation of the QoLVAD questionnaire demonstrated that the Brazilian Portuguese version can be applied to the Brazilian population. ABSTRACT Background: The use of long-term devices for chemotherapy in neoplastic diseases is very common. The CAVA trial was an extensive study that prospectively evaluated more than 1000 patients undergoing chemotherapy and randomly allocated them to three groups based on

15 January 2025 in medRxiv
Verified
Preprint
Open access
PDF file
BPBruno Jeronimo Ponte
Bruno Jeronimo Ponte
CSCarolina Carvalho Jansen Sorbello
Carolina Carvalho Jansen Sorbello
LBLucas Redivo Basani
Lucas Redivo Basani
MSMarcelo Fiorelli Alexandrino da Silva
Marcelo Fiorelli Alexandrino da Silva
MTMarcelo Passos Teivelis
Marcelo Passos Teivelis
NWNelson Wolosker
Nelson Wolosker
3. BACKGROUND AND HYPOTHESIS: Chronic kidney disease (CKD) represents a significant global public health challenge, affecting up to 13.4% of the population and ranking as the third fastest-growing cause of mortality. Progression of CKD to end stage kidney disease (ESKD) is the initial milestone for renal replacement therapy, which includes hemodialysis and renal transplantation, the latter marking the final therapy for ESKD patients. Arteriovenous fistulas (AVFs) are preferred for hemodialysis due to lower infection risks and superior patency compared to long-staying tunneled catheters (LSTC). Despite the importance of vascular access and transplantation, nationwide data correlating their utilization over time remains scarce. This study aimed to analyze outpatient hemodialysis vascular access procedures in Brazilian public health system from 2008 to 2022, comparing the temporal trends with renal transplantation. METHODS: This study employed a cross-sectional, population-based analysis of publicly available data pertaining outpatient vascular access procedures for hemodialysis and renal transplantation in the brazilian public health system between 2008 and 2022. Linear regression and correlation between both were then carried out. RESULTS: Between 2008 and 2022, 937,739 procedures were realized, including vascular access confection, ending procedures and renal transplants. Arteriovenous fistulas accounted for the majority of procedures (55%), followed by LSTC (34%), renal transplants in cadaveric donors (5.6%), catheter removals (2.2%), renal transplants with living donors (1.6%) and fistula ligation (1.4%). The increase in AVF creation was not proportional to the growth of the hemodialysis population (p<0.001) , in contrast to catheter implants, which increased substantially over the study period ( p<0.001 ). Vascular access-ending procedures demonstrated a significant correlation with renal transplants (p<0.001) . CONCLUSION: In Brazil, the number of LSTC for hemodialysis has increased over the years, while the number of AVFs significantly decreased. Additionally access-ending procedures, such as fistula ligation and catheter removals, have risen annually since 2010 and demonstrated a correlation with renal transplantation. Key Points:

8 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
CBClara Sanches Bueno
Clara Sanches Bueno
HSHedra Marques Santos
Hedra Marques Santos
JCJúlia Freire Castanheira
Júlia Freire Castanheira
BPBruno Jeronimo Ponte
Bruno Jeronimo Ponte
FPFelipe Soares Oliveira Portela
Felipe Soares Oliveira Portela
NWNelson Wolosker
Nelson Wolosker
Background: Venous thromboembolism (VTE) is a major global health concern, with inferior vena cava filters (VCFs) serving as an alternative to anticoagulation in high-risk patients. Brazil’s VCF trends remain understudied, particularly in its dual public-private healthcare system. This database study allows a broad overview of the Brazilian healthcare landscape. Methods: This retrospective nationwide analysis used Brazilian public (SUS/TabNet) and private (ANS/D-TISS) healthcare databases (2015–2023) to assess VCF placement rates, regional disparities and in-hospital mortality. Data included 21,630 procedures, analyzed via generalized linear models (Gamma/Poisson distributions). Results: The private system performed 57% of VCFs (12,323) despite covering only 25% of the population, with a 4.25-fold higher procedure rate per capita than the public system (29.45 vs. 6.42 per million). Women accounted for 57.8% of recipients. The Southeast region dominated (70% private, 40.5% public), while the North and Midwest had the lowest rates. Mortality rates were comparable (public 6.7% vs. private 7.4%, p = 0.066), peaking during COVID-19. Procedure volumes rose 140% over 9 years, contrasting with declining U.S. trends post-FDA restrictions. Conclusions: Brazil’s VCF use reflects systemic inequities, with private-system overrepresentation and regional gaps. This study enables unprecedented insights into large-scale VCF implementation across diverse healthcare subsystems.

20 February 2026 in Clinics
Verified
Journal Article
Open access
CBClara Sanches Bueno
Clara Sanches Bueno
HSHedra Marques Santos
Hedra Marques Santos
JCJúlia Freire Castanheira
Júlia Freire Castanheira
BPBruno Jeronimo Ponte
Bruno Jeronimo Ponte
FPFelipe Soares Oliveira Portela
Felipe Soares Oliveira Portela
NWNelson Wolosker
Nelson Wolosker
Venous Thromboembolism (VTE) is a major global health concern, with Vena Cava Filters (VCFs) serving as an alternative to anticoagulation in high-risk patients. Brazil's VCF trends remain understudied, particularly in its dual public-private healthcare system. This database study allows a broad overview of the Brazilian healthcare landscape. This cross-sectional nationwide analysis used Brazilian public (SUS/TabNet) and private (ANS/D-TISS) healthcare databases (2015-2023) to assess VCF placement rates, regional disparities, and in-hospital mortality. Data included 21,630 procedures, analyzed via generalized linear models (Gamma/Poisson distributions). The private system performed 57% of VCFs (12,323) despite covering only 25% of the population, with a 4.25-fold higher procedure rate per capita than the public system (29.45 vs. 6.42 per-million). Women accounted for 57.8% of recipients. The Southeast region dominated (70% private, 40.5% public), while the North and Midwest had the lowest rates. Mortality rates were comparable (public 6.7% vs. private 7.4%, p = 0.066), peaking during COVID-19. Procedure volumes rose 140% over 9-years, contrasting with declining U.S. trends post-FDA restrictions. Brazil's VCF use reflects systemic disparities, with private-system overrepresentation and regional gaps. This study enables unprecedented insights into large-scale VCF implementation across diverse healthcare subsystems.

5 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
JFJúlia Freire Castanheira de Paiva Ferreira
Júlia Freire Castanheira de Paiva Ferreira
TTThaís de Jesus Teani
Thaís de Jesus Teani
CBClara Sanches Bueno
Clara Sanches Bueno
BPBruno Jeronimo Ponte
Bruno Jeronimo Ponte
FPFelipe Soares Oliveira Portela
Felipe Soares Oliveira Portela
NWNelson Wolosker
Nelson Wolosker
Background: Chronic kidney disease (CKD) represents a growing public health challenge worldwide, particularly in low- and middle-income countries. In Brazil, where most patients with end-stage renal disease (ESRD) depend on the public healthcare system for dialysis and transplantation, ensuring adequate vascular access - among the options arteriovenous fistula (AVF) - is critical to sustaining treatment. Despite its clinical relevance, comprehensive national data on vascular access patterns across both public and private sectors have been historically limited. Objective: This study aimed to examine trends in AVF confection for hemodialysis across Brazil from 2015 to 2023, assessing differences in frequency, geographic distribution and sectorial disparities between the public and the private healthcare sector. Methods: A retrospective population-based analysis was conducted using anonymized data from national administrative databases: DATASUS (public sector) and D-TISS (private sector). The majority of AVF confection procedures were included. Statistical analyses considered regional adjustments and were performed using SPSS v.20, with significance set at p < 0.001. Results: Over the nine-year period, 376.383 AVF procedures were recorded, with 90,57% occurring in the public sector. While the absolute number of AVF confectioners increased, the ratio of AVFs per 1,000 dialysis patients showed a declining trend. Regional disparities were evident, with the Southeast and South regions presenting higher procedure rates compared to other areas. The private sector consistently reported lower confection rates. Conclusion: Although, separately, dialysis and AVFs rates have risen steadily in Brazil, the relative rate between than has decreasing trend over the years. The predominance of AVF procedures in the public system maintains higher when compared with the private sector.